Rho kinases in cardiovascular physiology and pathophysiology.
about
Functional SNP of ARHGEF10 confers risk of atherothrombotic strokeRegulation of calcium channels in smooth muscle: new insights into the role of myosin light chain kinaseApoptotic cell clearance: basic biology and therapeutic potential.Small G proteins in the cardiovascular system: physiological and pathological aspectsRho kinase enhances contractions of rat mesenteric collecting lymphaticsRho kinase as a target for cerebral vascular disordersLeptin augments coronary vasoconstriction and smooth muscle proliferation via a Rho-kinase-dependent pathwayPeptide substrates for Rho-associated kinase 2 (Rho-kinase 2/ROCK2)Rac1 and RhoA differentially regulate angiotensinogen gene expression in stretched cardiac fibroblastsmTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophyTGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteriesDisruption of vascular Ca2+-activated chloride currents lowers blood pressure.Smooth muscle specific Rac1 deficiency induces hypertension by preventing p116RIP3-dependent RhoA inhibition.LDL-induced impairment of human vascular smooth muscle cells repair function is reversed by HMG-CoA reductase inhibitionDirect role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications.Naturally Engineered Maturation of CardiomyocytesCalpain- and talin-dependent control of microvascular pericyte contractility and cellular stiffness.Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.Vascular and cellular calcium in normal and hypertensive pregnancyCerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.ERK-MAPK signaling opposes rho-kinase to reduce cardiomyocyte apoptosis in heart ischemic preconditioning.New trial designs and potential therapies for pulmonary artery hypertension.Synergistic effects of matrix nanotopography and stiffness on vascular smooth muscle cell function.Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis.Cell models to study regulation of cell transformation in pathologies of retinal pigment epithelium8,9-Epoxyeicosatrienoic acid analog protects pulmonary artery smooth muscle cells from apoptosis via ROCK pathway.Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice.ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice.Urotensin II alters vascular reactivity in animals subjected to volume overload.The Lbc Rho guanine nucleotide exchange factor α-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation.RhoA/Rho-kinase and vascular diseases: what is the link?BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathwaysAssociation analysis of polymorphisms in ROCK2 with cardiovascular disease in a Chinese population.Mechanosensing and Regulation of Cardiac Function.MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.Rho-kinase inhibition is involved in the activation of PI3-kinase/Akt during ischemic-preconditioning-induced cardiomyocyte apoptosis.Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice.PLCβ1-SHP-2 complex, PLCβ1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling?Rho-kinase activation in leukocytes plays a pivotal role in myocardial ischemia/reperfusion injury.
P2860
Q24293564-3945AB58-FA99-4C8B-A5B3-E93E6645DE8BQ26824005-94739E9D-C2A5-4386-A151-808DE579A4DBQ26825935-5F3FED7C-F18F-48F9-85C1-20590ED3F587Q27010607-343C7FD9-C90B-42AF-A91D-5DCA486ADB47Q27343052-C870F580-B900-46F2-8705-0F0896A5232BQ28081507-0B709B5D-045E-4D95-A028-5AB2C84B6EECQ28395130-50C5FB0B-1587-4D2C-B792-8DBF34684764Q28476345-DDE25D90-353B-49CF-9257-81C2D8ED587CQ28569683-3A55743C-8085-4D4C-AE71-B0A34F0257BCQ28583384-B2585398-12FC-4176-8B11-BC215021F526Q30440157-EA126E48-40FA-44B8-AB9C-00BBCAF08D06Q30486605-4BA37688-A16A-4963-9E66-C340E8A0544CQ30569762-C2FF4E27-1399-4FC8-8715-0FAA5E9824F5Q30618659-EB13DC5B-CA6F-4438-984C-89404EFA8034Q31068587-8BAB6392-B34D-41CD-8699-B68DB3124F6BQ33631289-6C2809BE-09AE-4A2A-A762-85F401573A33Q33639096-5A7F38E9-68C9-4F73-84A2-7F49F845E60AQ33657916-AE84AD34-C37E-4BD1-B273-9BBB06CB87DDQ33702090-3B9836D3-7DEB-476B-8717-161E3D83FED1Q33781354-D09401B9-E016-4D21-810B-529A5449E784Q33794968-BDAD7D2E-6559-44C5-A915-282F5EEC85A6Q33959183-5BE574CD-8597-4514-9560-B8A0BF59E2E9Q33982467-5470E229-2E78-4C44-85E0-8259ECA78850Q34063661-A1A1807A-D232-4332-9D98-A3CC41BA6726Q34079529-026B51D2-C640-4CA2-8760-7F0CBD260FF6Q34080190-57D74C06-0E56-4C59-A5BE-2C4AA4AFEB7DQ34082360-28588A9D-018E-4772-B3BE-395BFE774B57Q34090173-47922661-65B8-48AF-A689-53F2CD2ACBD0Q34172718-D5B68A2D-7063-4A6D-AC7B-53934C49B7C0Q34192302-1EB46CD1-8E54-4FD7-A58A-7FA8620F3122Q34236903-B79D8D90-7F10-468C-A47E-2686ED6D5E36Q34378293-BEDE1BC6-205E-4C37-9D10-B0F9D6EFBF8FQ34483074-3E29F47C-D86D-4CC6-B4ED-4B7A4EE8E348Q34551911-7A46B56B-1113-4CB7-96B2-A613126A8D8DQ34632608-8326181F-D152-49FC-B1E0-2C3ECBB38D15Q34719895-F30A12A7-542A-47BD-98F9-C2F1DEA8D384Q34769863-9B53BD26-AAE5-4B14-A2E8-E6A5BE6CD4ABQ34950411-BDA030E2-6124-45F8-AE9B-180B38197028Q35061384-37DDCB00-F4D0-4728-A02B-2C548ED30DC5Q35123172-74262B99-B3A2-468E-9A41-DEFAF013537A
P2860
Rho kinases in cardiovascular physiology and pathophysiology.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Rho kinases in cardiovascular physiology and pathophysiology.
@ast
Rho kinases in cardiovascular physiology and pathophysiology.
@en
type
label
Rho kinases in cardiovascular physiology and pathophysiology.
@ast
Rho kinases in cardiovascular physiology and pathophysiology.
@en
prefLabel
Rho kinases in cardiovascular physiology and pathophysiology.
@ast
Rho kinases in cardiovascular physiology and pathophysiology.
@en
P2093
P1433
P1476
Rho kinases in cardiovascular physiology and pathophysiology.
@en
P2093
Gervaise Loirand
Patrice Guérin
Pierre Pacaud
P304
P356
10.1161/01.RES.0000201960.04223.3C
P577
2006-02-01T00:00:00Z